Logo image of 1EVT.MI

EVOTEC SE (1EVT.MI) Stock Overview

Europe - BIT:1EVT - DE0005664809 - Common Stock

6.038 EUR
-0.22 (-3.45%)
Last: 9/29/2025, 7:00:00 PM

1EVT.MI Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap2.14B
Shares355.11M
Float315.87M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.11
PEN/A
Fwd PEN/A
Earnings (Next)11-05 2025-11-05/bmo
IPO10-11 1999-10-11
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


1EVT.MI short term performance overview.The bars show the price performance of 1EVT.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

1EVT.MI long term performance overview.The bars show the price performance of 1EVT.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1EVT.MI is 6.038 EUR.

EVOTEC SE / 1EVT Daily stock chart

1EVT.MI Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TN8.DE THERMO FISHER SCIENTIFIC INC 24.41 172.00B
DAP.DE DANAHER CORP 28.82 132.47B
1DHR.MI DANAHER CORP 28.66 131.68B
LO3.DE LONZA GROUP AG-REG 35.74 41.65B
QTS.DE IQVIA HOLDINGS INC 17.93 29.81B
DIM.PA SARTORIUS STEDIM BIOTECH 48.03 19.31B
56S1.DE SARTORIUS STEDIM BIOTECH 47.26 19.00B
SRT3.DE SARTORIUS AG-VORZUG 51.98 16.93B
SRT.DE SARTORIUS AG 42.39 13.81B
ILU.DE ILLUMINA INC 24.02 13.11B
ERF.PA EUROFINS SCIENTIFIC 17.26 11.32B
ESF0.DE EUROFINS SCIENTIFIC 17.25 11.31B

About 1EVT.MI

Company Profile

1EVT logo image Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. The company is headquartered in Hamburg, Hamburg and currently employs 4,759 full-time employees. The firm is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Company Info

EVOTEC SE

Essener Bogen 7

Hamburg HAMBURG DE

Employees: 4759

1EVT Company Website

1EVT Investor Relations

Phone: 4940560810

EVOTEC SE / 1EVT.MI FAQ

What is the stock price of EVOTEC SE today?

The current stock price of 1EVT.MI is 6.038 EUR. The price decreased by -3.45% in the last trading session.


What is the ticker symbol for EVOTEC SE stock?

The exchange symbol of EVOTEC SE is 1EVT and it is listed on the Euronext Milan exchange.


On which exchange is 1EVT.MI stock listed?

1EVT.MI stock is listed on the Euronext Milan exchange.


What is the price forecast or stock price prediction for EVOTEC SE stock?

12 analysts have analysed 1EVT.MI and the average price target is 9.47 EUR. This implies a price increase of 56.86% is expected in the next year compared to the current price of 6.038. Check the EVOTEC SE stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EVOTEC SE worth?

EVOTEC SE (1EVT.MI) has a market capitalization of 2.14B EUR. This makes 1EVT.MI a Mid Cap stock.


How many employees does EVOTEC SE have?

EVOTEC SE (1EVT.MI) currently has 4759 employees.


Is EVOTEC SE (1EVT.MI) expected to grow?

The Revenue of EVOTEC SE (1EVT.MI) is expected to decline by -1.21% in the next year. Check the estimates tab for more information on the 1EVT.MI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EVOTEC SE (1EVT.MI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EVOTEC SE (1EVT.MI) stock pay dividends?

1EVT.MI does not pay a dividend.


When does EVOTEC SE (1EVT.MI) report earnings?

EVOTEC SE (1EVT.MI) will report earnings on 2025-11-05, before the market open.


What is the Price/Earnings (PE) ratio of EVOTEC SE (1EVT.MI)?

EVOTEC SE (1EVT.MI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.11).


1EVT.MI Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to 1EVT.MI.


Chartmill TA Rating
Chartmill Setup Rating

1EVT.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to 1EVT.MI. 1EVT.MI may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1EVT.MI Financial Highlights

Over the last trailing twelve months 1EVT.MI reported a non-GAAP Earnings per Share(EPS) of -1.11. The EPS decreased by -136.17% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -8.6%
ROE -18.39%
Debt/Equity 0.42
Chartmill High Growth Momentum
EPS Q2Q%55.56%
Sales Q2Q%-5.98%
EPS 1Y (TTM)-136.17%
Revenue 1Y (TTM)-1.41%

1EVT.MI Forecast & Estimates

12 analysts have analysed 1EVT.MI and the average price target is 9.47 EUR. This implies a price increase of 56.86% is expected in the next year compared to the current price of 6.038.

For the next year, analysts expect an EPS growth of 57.39% and a revenue growth -1.21% for 1EVT.MI


Analysts
Analysts76.67
Price Target9.47 (56.84%)
EPS Next Y57.39%
Revenue Next Year-1.21%

1EVT.MI Ownership

Ownership
Inst Owners60.42%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A